Eventide Asset Management - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 208 filers reported holding MIRATI THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$26,136,000
+20.6%
600,0000.0%0.47%
+28.4%
Q2 2023$21,678,000
+57.1%
600,000
+61.7%
0.37%
+44.7%
Q1 2023$13,797,572
+49.6%
371,102
+82.3%
0.25%
+39.0%
Q4 2022$9,225,116
-35.1%
203,6000.0%0.18%
-35.0%
Q3 2022$14,219,000
+87.4%
203,600
+80.2%
0.28%
+72.8%
Q2 2022$7,586,000
-79.7%
113,000
-75.1%
0.16%
-72.3%
Q1 2022$37,310,000
-12.8%
453,781
+55.6%
0.58%
+6.9%
Q4 2021$42,779,000
+86.8%
291,626
+125.2%
0.55%
+81.1%
Q3 2021$22,905,000
+9.5%
129,4710.0%0.30%
+7.5%
Q2 2021$20,913,000
-5.7%
129,4710.0%0.28%
-14.6%
Q1 2021$22,178,000
-22.0%
129,4710.0%0.33%
-24.5%
Q4 2020$28,437,000
-43.1%
129,471
-57.0%
0.44%
-55.4%
Q3 2020$49,981,000
+45.4%
301,0000.0%0.98%
+30.9%
Q2 2020$34,365,000
+48.5%
301,0000.0%0.75%
-0.3%
Q1 2020$23,138,000
-40.3%
301,0000.0%0.75%
-31.5%
Q4 2019$38,787,000
+65.4%
301,0000.0%1.09%
+41.0%
Q3 2019$23,451,000
-6.3%
301,000
+23.9%
0.78%
+1.8%
Q2 2019$25,029,000243,0000.76%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders